Original Research

Pharmacokinetic and pharmacodynamic properties of a new biosimilar filgrastim TPI G-CSF in comparison to the marketed reference filgrastim Neupogen®: a double-blind, single-dose, two-period crossover trial

Niazi SK

Biosimilars 2015, 5:93-101

Published Date: 3 November 2015